EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Deletion Testing of the DEGS1 Gene Should Be Part of the Diagnostic Pipeline for Hypomyelinating Leukodystrophy (HLD18)

Mariateresa Zanobio iD, Francesca Nardecchia iD, Gerarda Cappuccio iD, Maria Elena Onore iD, Pasquale Di Letto iD, Sarah Iffat Rahman iD, Gaetano Terrone iD, Lorenzo Ugga iD, Agnese De Giorgi iD, Michele Dei Cas iD, Marco Trinchera iD, Vincenzo Leuzzi iD und 5 weitere

Human Mutation · 2025

DOI: 10.1155/humu/3531508 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Human Mutation, 2025. Verfasst von Mariateresa Zanobio und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy. Hauptthemen laut MEDLINE: Gene Deletion, Hereditary Central Nervous System Demyelinating Diseases. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NextGenerationEU, Fondazione Telethon.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypomyelinating leukodystrophies are a heterogeneous group of disorders characterized by abnormal myelin formation in the central nervous system. Thanks to the increased use of NGS, a growing number of pathogenic single nucleotide variants in DEGS1 have recently been reported to be responsible for hypomyelinating leukodystrophy 18 (HLD18), a rare and severe autosomal recessive form. DEGS1 is a small gene (4 exons and 17 kb) encoding Δ 4‐dihydroceramide desaturase, which catalyzes the final step in ceramide biosynthesis. Here, we present two patients from unrelated families affected by severe and progressive white matter disease with developmental delay with or without regression and severe intellectual disability. Trio exome sequencing (ES) revealed in both probands two homozygous missense variants in the DEGS1 gene, p.Asp16His and p.Asn255Ser, both inherited from their heterozygous healthy mothers and with a noncarrier father. This curious finding of inconsistent segregation data raises the need for further testing. There is no MLPA test available for this gene, as no deletions have been reported. However, we tried a customized high‐resolution 1 M CGH array, which was surprisingly positive in both cases: a 63‐kb heterozygous deletion encompassing the entire gene in one proband and a 7‐kb heterozygous deletion of Exons 2–3 in the second case. Previously reported cases of HLD18 have all been found to carry single nucleotide pathogenic variants in DEGS1 , and the two patients described here are the first to carry whole or partial microdeletions involving DEGS1 that unmask pathogenic missense variants on the other allele. These two cases report the first examples of microdeletions of DEGS1 that unmask recessive allele pathogenic variants, underscoring the importance of considering whole or partial gene deletions in the diagnostic pipeline.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene DeletionHereditary Central Nervous System Demyelinating DiseasesChild, PreschoolFemaleHumansMaleExome SequencingMutation, MissensePedigreePhenotypeAdolescent

Autor:innen und Institutionen

  • Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy.
  • Child Neurology, Department of Translational Medicine, Federico II University, Naples, Italy.
  • Department of Translational Medicine, University of Naples "Federico II", Naples, Italy.
  • Department of Health Sciences, University of Milan, Milano, Italy.
  • Department of Medicine and Surgery (DMC), University of Insubria, Varese, Italy.

ORCID-Profile: Mariateresa Zanobio, Francesca Nardecchia, Gerarda Cappuccio, Maria Elena Onore, Pasquale Di Letto, Sarah Iffat Rahman, Gaetano Terrone, Lorenzo Ugga, Agnese De Giorgi, Michele Dei Cas, Marco Trinchera, Vincenzo Leuzzi, Giulio Piluso, Vincenzo Nigro, Nicola Brunetti-Pierri, Annalaura Torella

Förderung

  • NextGenerationEU
  • Fondazione Telethon

Zitieren

APA

Zanobio, M., Nardecchia, F., Cappuccio, G., Onore, M. E., Di Letto, P., Rahman, S. I., Terrone, G., Ugga, L., De Giorgi, A., Cas, M. D., Trinchera, M., Leuzzi, V., Piluso, G., Nigro, V., Brunetti-Pierri, N., TUDP consortium, & Torella, A. (2025). Deletion Testing of the DEGS1 Gene Should Be Part of the Diagnostic Pipeline for Hypomyelinating Leukodystrophy (HLD18). Human Mutation. https://doi.org/10.1155/humu/3531508

Vancouver

Zanobio M, Nardecchia F, Cappuccio G, Onore ME, Di Letto P, Rahman SI, et al. Deletion Testing of the DEGS1 Gene Should Be Part of the Diagnostic Pipeline for Hypomyelinating Leukodystrophy (HLD18). Human Mutation. 2025. doi:10.1155/humu/3531508

BibTeX
@article{Zanobio2025,
  author = {Zanobio, Mariateresa and Nardecchia, Francesca and Cappuccio, Gerarda and Onore, Maria Elena and Di Letto, Pasquale and Rahman, Sarah Iffat and Terrone, Gaetano and Ugga, Lorenzo and De Giorgi, Agnese and Cas, Michele Dei and Trinchera, Marco and Leuzzi, Vincenzo and Piluso, Giulio and Nigro, Vincenzo and Brunetti-Pierri, Nicola and TUDP consortium, TUDP consortium and Torella, Annalaura},
  title = {Deletion Testing of the DEGS1 Gene Should Be Part of the Diagnostic Pipeline for Hypomyelinating Leukodystrophy (HLD18)},
  journal = {Human Mutation},
  year = {2025},
  doi = {10.1155/humu/3531508}
}
Kostenlos starten →